Reuters logo
BRIEF-Cytokinetics reports Q3 loss of ‍$0.60/shr​
2017年10月26日 / 晚上8点08分 / 1 个月前

BRIEF-Cytokinetics reports Q3 loss of ‍$0.60/shr​

Oct 26 (Reuters) - Cytokinetics Inc

* Cytokinetics, Inc. reports third quarter 2017 financial results

* Q3 revenue $6.2 million versus I/B/E/S view $6.5 million

* Cytokinetics Inc - qtrly loss per share ‍$0.60​

* Cytokinetics Inc- ‍anticipates cash research and development expenses will be in range of $103 million to $107 million for 2017​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below